Skip to main content

Table 4 Select/relevant genes with significant differential gene expression between the lipopolysaccharide-challenged control group and the unchallenged control group

From: Effects of hyaluronan treatment on lipopolysaccharide-challenged fibroblast-like synovial cells

Genbank accession number Equine gene Fold change (group 2/group 1) P value
AY114351 Granulocyte chemotactic protein 2 10.0 <0.0001
CD528275 Interferon-induced protein 0.03 <0.0001
CD468799 GRO3 oncogene 10.0 <0.0001
BI960809 TNF╬▒ 2.5 0.0001
AJ251189 Chemoattractant protein-1 3.33 0.0016
CD536631 GRO2 oncogene 10.0 0.0002
BM734848 Chondroitin sulfate proteoglycan 2 2.0 0.0005
AB035518 Adrenomullin 0.42 0.0006
AF230359 Urokinase plasminogen activator receptor 1.67 0.0009
AF053497 Melanoma growth stimulatory activity homolog 5.0 0.0014
AF027335 Prostaglandin G/H synthase-2 3.33 0.0021
U62529 Matrix metalloproteinase 3 2.0 0.0026
CD467591 Heat shock protein 70 2.5 0.0027
AY056582 Hyaluronic acid synthase 2 5.0 0.0028
U64794 IL-6 2.0 0.0037
  1. Three individual donors are represented for each group. Group 1, unchallenged control; group 2, lipopolysaccharide-challenged control.